Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Sacubitril/valsartan inhibits the proliferation of vascular smooth muscle cells through notch signaling and ERK1/2 pathway

Fig. 2

The effect of Entresto on VSMCs proliferation stimulated by AngII. 1: Control group, 2: AngII (10− 6mol/L) group, 3: AngII (10− 6mol/L) + Entresto (10− 5mol/L) group, 4: AngII (10− 6mol/L) + Entresto (10− 6mol/L) group. (1) Entresto was used for 1 h before Ang II stimulation for 24 h, and CCK8 was used to detect the cell inhibition rate of each group. a: p < 0.05, compared with the control group. b: p < 0.05, compared with Ang II group

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us